您的位置: 首页 > 农业专利 > 详情页

Methods of treatment using selective Bcl-2 inhibitors
专利权人:
AbbVie Ireland Unlimited Company
发明人:
Elmore, Steven,Souers, Andrew,Wang, Li Chun,Ghayur, Tariq,Perper, Stuart J.
申请号:
AU2016204396
公开号:
AU2016204396A1
申请日:
2016.06.27
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
#$%^&*AU2016204396A120160714.pdf#####METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS Abstract This invention pertains to methods of treating systemic lupus erythematosus, lupus nephritis or Sjogren's Syndrome with compounds that selectively inhibit the activity of Bcl-2 anti apoptotic proteins. Specifically, the current invention is directed to treatment with compounds that selectively inhibit the activity of Bcl-2 proteins, with a lesser affinity for inhibiting the activity of other BCL-2 family proteins, including Bel-XL-
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充